Sec Form 4 Filing - WEIL JOHN D @ ALLIED HEALTHCARE PRODUCTS INC - 2020-11-12

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
WEIL JOHN D
2. Issuer Name and Ticker or Trading Symbol
ALLIED HEALTHCARE PRODUCTS INC [ AHPI]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X __ Director X __ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle)
CLAYTON MANAGEMENT COMPANY, 4625 LINDELL BLVD., #335
3. Date of Earliest Transaction (MM/DD/YY)
11/12/2020
(Street)
ST LOUIS, MO63108
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 60,520 ( 1 ) I Trust
Common Stock 90,513 D
Common Stock 2,500 I IRA
Common Stock 94,427 ( 2 ) I Spouse
Common Stock 59,101 ( 3 ) I Trust
Common Stock 7,514 ( 4 ) I Corporation
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option to purchase common stock $ 7.1 11/10/2012 11/10/2021 Common stock 750 750 D
Option to purchase common stock $ 5.18 11/08/2013 11/08/2022 Common stock 750 750 D
Option to purchase common stock $ 4.62 11/14/2014 11/14/2023 Common stock 750 750 D
Option to purchase common stock $ 3.16 11/13/2015 11/13/2024 Common stock 750 750 D
Option to purchase common stock $ 2.34 11/12/2016 11/12/2025 Common stock 750 750 D
Option to purchase common stock $ 2.26 11/10/2017 11/10/2026 Common stock 750 750 D
Option to purchase common stock $ 2.22 11/09/2018 11/09/2027 Common stock 750 750 D
Option to purchase common stock $ 2.13 11/08/2019 11/08/2028 Common stock 750 750 D
Option to purchase common stock $ 1.17 11/07/2020 11/07/2029 Common stock 750 750 D
Option to purchase common stock $ 7.86 11/12/2020 11/12/2020 A 750 11/12/2021 11/12/2030 Common stock 750 ( 5 ) $ 0 750 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
WEIL JOHN D
CLAYTON MANAGEMENT COMPANY
4625 LINDELL BLVD., #335
ST LOUIS, MO 63108
X X
Signatures
John D. Weil 11/16/2020
Signature of Reporting Person Date
Explanation of Responses:
( 1 )Owned by trusts for which the reporting person acts as co-trustee and with respect to which the reporting person disclaims any economical benefit in such shares.
( 2 )The reporting person disclaims any economic benefit in such shares.
( 3 )Owned by a trust for the benefit of the reporting person and for which the reporting person acts as co-trustee.
( 4 )Owned by a corporation controlled by the reporting person.
( 5 )Issued pursuant to the Company's 2013 Director's Stock Option Plan.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.